FibroGen
FGEN | NASDAQ
$9.07
-$0.15 (-1.63%)
At close: Jan 12, 2026, 09:30 AM ET
-1.63%
(1D)Rating
Key Statistics
Market Data
Market Cap $36.69M
1D Range
9.02 9.21
52W Range
4.85 21.95
Valuation (TTM)
PE 0.20
PB -4.51
EV/EBITDA 1.45
Valuation (NTM)
Forward PE N/A
Forward PEG 0.00
Price Target $28.00
Cash Flow
FCF Yield -103.7%
SBC Adj. FCF Yield -114.6%
SBC Impact -10.5%
Margins
Gross Margin 78.4%
Operating Margin -1090.0%
FCF Margin -824.6%
Growth (CAGR)
Revenue 3Y | 5Y -67.2% |
-51.5%
Dil EPS 3Y | 5Y 198.8% |
149.4%
FCF 3Y | 5Y 93.5% |
32.4%
Returns
ROA 181.2%
ROE -2443.6%
ROIC -77.4%
Financial Health
Net Cash
$91.32M
Current Ratio 2.69
Interest Coverage 82.62
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
FibroGen, Inc. is a biopharmaceutical firm dedicated to discovering, developing, and bringing to market therapies that address significant medical conditions currently lacking effective treatments. Am...
Sector Healthcare
Industry Biotechnology
Employees 225
IPO Date Nov 14, 2014
Website www.kyntrabio.com
Fiscal Year January - December
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove FGEN